Weekly Digest - Mar 2024

Weekly Digest - Mar 2024

26 Feb 2024: Nona Biosciences and Boostimmune unite for Cutting-edge ADC development

  • Nona Biosciences, a global biotechnology company, collaborates with Boostimmune to expedite Antibody-Drug Conjugates development using Harbour Mice H2L2 platform for innovative cancer therapies
  • Harbour Mice generates fully human mAbs in classical two light and two heavy chains (H2L2) format, and heavy chain only (HCAb) format
  • Integrating Harbour Mice and a single B cell cloning platform, Nona Biosciences is focused on driving global inventions of transformative next-generation drugs
  • Boostimmune was co-founded in 2021 by Professor Tadatsugu Taniguchi, who originally identified interferon beta, interleukin-2, and interferon regulatory factors (IRFs)

For full story click here

Share this